ארצות הברית - אנגלית - NLM (National Library of Medicine)

naari pte. limited - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s), estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol and norethindrone acetate tablets is indicated for: limitation of use when prescribing solely for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause, topical vaginal products should be considered. limitation of use when prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. consider estrogen therapy only for women at significant risk of osteoporosis. estradiol and norethindrone acetate tablets are contraindicated in women with any of the following conditions: • undiagnosed abnormal genital bleeding [see warnings and precautions (5.2)] • breast cancer or history of breast cancer [see warnings and precautions (5.2)] • estrogen-dependent neoplasia [see warnings and precautions (5.2)] • active dvt, pe, or history of these conditions [see warnings and precautions (5.1)] • active arterial thromboembolic disease (for example, stroke and

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - estradiol hemihydrate 1.03mg equivalent to 1 mg oestradiol;  ;  ;  ; norethisterone acetate 0.5mg;  ;  ;   - film coated tablet - active: estradiol hemihydrate 1.03mg equivalent to 1 mg oestradiol       norethisterone acetate 0.5mg       excipient: copovidone hypromellose lactose monohydrate magnesium stearate maize starch purified talc triacetin

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - estradiol hemihydrate 1.55mg equivalent to estradiol 1.5 mg;  ; nomegestrol acetate 2.5mg;  ;   - tablet - 2.5mg/1.5mg - active: estradiol hemihydrate 1.55mg equivalent to estradiol 1.5 mg   nomegestrol acetate 2.5mg     excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry white 85f18422 purified talc colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 85f32865 purified talc - oral contraception

ישראל - אנגלית - Ministry of Health

j-c health care ltd - estradiol as hemihydrate; estradiol as hemihydrate; norethisterone acetate - patches - estradiol as hemihydrate 3.2 mg; norethisterone acetate 11.2 mg; estradiol as hemihydrate 3.2 mg - estradiol, combinations - estradiol, combinations - hormone replacement therapy for the relief of menopausal symptoms.

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - estradiol hemihydrate - film-coated tablet - 2 milligram(s) - natural and semisynthetic estrogens, plain; estradiol

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - estradiol hemihydrate - film-coated tablet - 1 milligram(s) - natural and semisynthetic estrogens, plain; estradiol

ארצות הברית - אנגלית - NLM (National Library of Medicine)

kaiser foundation hospitals - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 0.5 mg - estradiol tablets usp are indicated in the: - treatment of moderate to severe vasomotor symptoms associated with the menopause. - treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. - treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure. - treatment of breast cancer (for palliation only) in appropriately selected women and men with metastatic disease. - treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only). - prevention of osteoporosis. when prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and for whom non-estrogen medications are not considered to be appropriate. (see clinical pharmacology , clinical studies .) the mainstays for decreasing the risk of postmenop

ארצות הברית - אנגלית - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 1 mg - estradiol tablets usp are indicated in the: estrogens should not be used in individuals with any of the following conditions:

ארצות הברית - אנגלית - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 1 mg - estradiol tablets usp are indicated in the: - treatment of moderate to severe vasomotor symptoms associated with the menopause. - treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. - treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure. - treatment of breast cancer (for palliation only) in appropriately selected women and men with metastatic disease. - treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only). - prevention of osteoporosis. when prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and for whom non-estrogen medications are not considered to be appropriate. (see clinical pharmacology , clinical studies .) - the mainstays for decreasing the risk of postmeno

ארצות הברית - אנגלית - NLM (National Library of Medicine)

bryant ranch prepack - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 0.5 mg - estradiol tablets are indicated in the: the mainstays for decreasing the risk of postmenopausal osteoporosis are weight bearing exercise, adequate calcium and vitamin d intake, and when indicated, pharmacologic therapy. postmenopausal women require an average of 1500 mg/day of elemental calcium. therefore, when not contraindicated, calcium supplementation may be helpful for women with suboptimal dietary intake. vitamin d supplementation of 400 to 800 iu/day may also be required to ensure adequate daily intake in postmenopausal women. estrogens should not be used in individuals with any of the following conditions: